The activity of pyrazolo[4,3- e ][1,2,4]triazine and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures-Reference-Cited by-同舟云学术

The activity of pyrazolo[4,3- e ][1,2,4]triazine and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures

Published:2024-05-03 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Szymanowska Anna¹²,Radomska Dominika³,Czarnomysy Robert³,Mojzych Mariusz⁴,Kotwica-Mojzych Katarzyna⁵,Bielawski Krzysztof³,Bielawska Anna¹

Affiliation:

1. Department of Biotechnology, Medical University of Bialystok, Bialystok, Poland

2. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

3. Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Bialystok, Poland

4. Department of Chemistry, Siedlce University of Natural Sciences and Humanities, Siedlce, Poland

5. Laboratory of Experimental Cytology, Medical University of Lublin, Lublin, Poland

Funder

Medical University of Bialystok

Siedlce University of Natural Sciences and Humanities

Medical University of Lublin

Polish National Agency for Academic Exchange (NAWA) within the Bekker Programme

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2024.2343352

Reference81 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2020

2. Mathers CD Boschi-Pinto C Lopez AD Murray CJL World Health Organization. Cancer incidence mortality and survival by site for 14 regions of the world; 2001. Geneva. https://apps.who.int/iris/handle/10665/67775.

3. Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping

4. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

5. Why do cancers have high aerobic glycolysis?